Business Overview

Active

2012

73

0.6%

$176.3M

Grant

4

13

3.4 years

Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. Atomwise has strengthened its drug discovery and development expertise by expanding its Board of Directors and creating a Scientific Advisory Board (SAB). These appointments signal a critical milestone for Atomwise as the company focuses on its own internal pipeline. We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any other AI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster. We’re at a critical time in history where our need for new kinds of medicines is greater than any time in human memory. Fortunately, we can leverage advancing technology and scientific breakthroughs to accelerate discovery. New data, new algorithms, new compute platforms lift all of us, enable our work on the hardest of problems, empower us to invent and create, and ultimately save one billion lives. Join us: www.atomwise.com/careers

Employee Count

0.6%

2%

1.2%

-15.8%

Employee counts updated on a monthly basis.

Lists

News

Stock Chart

Founders (2)

NamePositionMilitaryClassificationContact
hiddenAbraham Heifets
CEO
hiddenIzhar Wallach
CTOAI Expert

AI Team (0)

Board and Advisors (0)

Revenues (0)

Funding Rounds (4)

$174M

RoundDateCapital RaisedValuationInvestors
October 2020
hidden$2.3M
August 2020
hidden$123M
8
March 2018
hidden$45M
9
June 2015
hidden$6M
5

M&A Events (0)

Investors (13)

InvestorInvestor TypeLocation
hiddenY Combinator
Venture CapitalUnited States
hiddenKhosla
Venture CapitalUnited States
hiddenDCVC (Data Collective)
Venture CapitalUnited States
hiddenB Capital Group
Venture CapitalUnited States
hiddenBaidu
CompanyChina
hiddenThreshold Ventures
Venture CapitalUnited States
hiddenDolby Ventures
Corporate Venture CapitalUnited States
hiddenMonsanto Growth Ventures
Venture CapitalUnited States
hiddenTencent Holdings
CompanyChina
hiddenSanabil Investments
GovernmentSaudi Arabia
hiddenAME Cloud Ventures
Venture CapitalUnited States
hiddenBV
hiddenOS Fund

Certifications (0)

AI Technology Stack

17

Atomwise uses artificial intelligence to help discover new medicines and agricultural compounds. Its groundbreaking AtomNet technology reasons like a human chemist, using powerful deep learning algorithms and supercomputers to analyze millions of potential molecules each day. Neural network architectures to predict protein-ligand binding affinity for drug discovery.

Jobs (0)

NameStatusFoundedStageFundingValuationEmployees1YR Headcount GrowthFounder UnitsFounder Classification

Pro Lite Subscription Required

Unlock all profile details

With a Pro Lite subscription, you can enjoy unlimited profile viewing with access to hidden details. Power your innovation efforts, uninterrupted.

$20/month

cancel anytime

Pro Lite includes:

Pro Subscription Required

View all verified emails

With a Pro subscription, you can enjoy unlimited profile viewing, export our entire database, and view verified email contacts. Power your innovation efforts, uninterrupted.

$50/month

cancel anytime

Pro includes:

StartupHub.ai

StartupHub.ai, the hub of the AI startup ecosystem.

Add or Claim Your Profile

Submit the form below to add or claim an existing profile. Within 24 hours, we'll review your request and connect you to your existing profile for full editing.

Pro Lite Subscription Required

Unlock all search results

With a Pro Lite subscription, you can enjoy unlimited profile viewing. Power your innovation efforts, uninterrupted.

$20/month

cancel anytime

Pro Lite includes: